Sartorius | SRT3 - Gross Profit On Sales


Sartorius reported EUR433.1M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Avita Medical AUD 14.31M 639K Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Moderna USD -566M 792M Mar/2026
Organon & Co USD 783M 71M Mar/2026
Revvity USD 416.87M 29.21M Jun/2026
Sartorius EUR 433.1M 18.6M Jun/2026
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.57B 193.9M Jun/2026
Xeris Pharmaceuticals USD 72.55M 404K Mar/2026